Further analyses of clinical BC data indicate that DAXX expression levels positively correlate with that of SREBF1 and SREBF2 (Supplementary Fig. S4d) and a panel of lipogenic genes (Supplementary Fig. S1e). This evidence concerns the gene DAXX and breast cancer.